GENE ONLINE|News &
Opinion
Blog

EMA
Trials & Approvals CRISPR Genome Editing
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
Regulatory Gene Therapy
EMA Plans to Issue Liver Failure Warning for Novartis’ Gene Therapy
2023-01-16
Regulatory EMA
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
COVID-19 AstraZeneca
AstraZeneca’s COVID-19 Vaccine Finally Wins Full Authorization in the European Union
2022-11-01
Trials & Approvals Drug Withdrawal
EMA Upholds Recommendation For Withdrawing Marketing Authorization for Amfepramone Obesity Medicines
2022-10-28
Trials & Approvals EMA
AbbVie and Genmab’s Joint Cancer Treatment Receives EMA Validation
2022-10-28
Trials & Approvals EMA
Atara, Pierre Fabre’s EBV T-Cell Therapy Recommended For Approval In Europe
2022-10-17
Trials & Approvals Cervical Cancer
EMA Signals Positive Opinion for Regeneron’s Cervical Cancer Monotherapy
2022-10-14
Trials & Approvals B-cell Lymphoma
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
Trials & Approvals Streptococcus Pneumoniae
Merck’s Vaccine For Streptococcus Pneumoniae Lined Up for Another European Commission Approval
2022-09-16
Trials & Approvals Orphan Drug
BioCryst’s ALK-2 Inhibitor Granted FDA Orphan Drug Status For Rare Bone Disease
2022-09-01
Trials & Approvals EMA
EMA Accepts Daiichi Sankyo’s Marketing Application For Leukemia Drug
2022-08-24
Trials & Approvals Monkeypox
EMA Announces Advice on Switch that Could Increase The Monkeypox Vaccine Supply
2022-08-19
COVID-19 Vaccine
EMA Begins Review of SK biosciences’ New Non-mRNA COVID-19 vaccine
2022-08-18
Trials & Approvals Crohn’s disease
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
1 2
LATEST
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
Breakthrough Screening Platform to Assess SARS-CoV-2 Mutations and Potential Treatments
2024-04-16
Join Us for the SABPA OC/LA 16th Annual Biomedical Forum!
2024-04-16
Sequencing Revolution Spotlights the Titans of NGS Innovation
2024-04-16
Oncology’s New Drugs on the Horizon (II): Radiotherapy, Radioligands & Other Therapeutic Agents
2024-04-12
READ MORE
EVENT
2024-04-20
16th SABPA OC/LA Annual Biomedical Forum
The Beckman Center, 100 Academy, Irvine, CA, 92617
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top